MedPath

Is the function of HDL cholesterol impaired in COPD and whether inhaled steroids can improve HDL function?

Phase 4
Conditions
Health Condition 1: null- Severe exacerbation of Chronic Obstructive Pulmonary Disease requiring hospitalization.
Registration Number
CTRI/2016/03/006773
Lead Sponsor
PSG Institute of Medical Sciences and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Age 40 years and above.

Smoking history with more than 10 pack years.

Physician diagnosed severe exacerbation of COPD requiring hospitalization.

Willing to participate in the study adhering to its protocol.

Exclusion Criteria

History suggestive of asthma.

History of past or coexisting malignancy, connective tissue disorders and other chronic inflammatory disorders.

Coexisting poorly controlled diabetes mellitus (HbA1C > 8.5%), pneumonia and active tuberculosis.

Subjects requiring ICU stay with or without life support for management of severe exacerbation of COPD.

Mental status not competent enough to consent for the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath